Summit Therapeutics CFO Buys 100k Shares Amid Volatile Market – Signals Long‑Term Confidence
Summit Therapeutics CFO’s 100k share purchase shows long‑term confidence amid volatility—insider buy hints at future upside tied to clinical milestones.
3 minutes to read